ADALIMUMAB ACHIEVES COMPLETE REMISSION AT 52 WEEKS IN JAPANESE PATIENTS WITH INTESTINAL BEHÇET'S DISEASE

Fumihito Hirai  1     Satoshi Tanida  2     Nagamu Inoue  3     Makoto Naganuma  3     Anne Camez  4     Bidan Huang  4     Vipin Arora  4     Morio Ozawa  5     Toshifumi Hibi  6     Roopal B Thakkar  4    
1 Fukuoka University Chikushi Hospital
2 Nagoya City University Hospital
3 Keio University School of Medicine
4 AbbVie
5 AbbVie GK
6 Kitasato Institute Hospital

Session
IBD III

Conference
UEG Week 2013

Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A521


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing